Clinical Trials Browser

Phase 3 × Non-Muscle Invasive Bladder Neoplasms × hydroxycamptothecinum × Clear all

NCT07424287 2026-02-20

A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC

Phase 3 Not yet recruiting

Non-Muscle Invasive Bladder Neoplasms